Literature DB >> 26836494

Fertility and pregnancy in the Fontan population.

Dominica Zentner1, Aneta Kotevski2, Ingrid King2, Leeanne Grigg3, Yves d'Udekem4.   

Abstract

BACKGROUND: Women with a Fontan circulation are deemed at significantly increased risk of maternal morbidity and mortality during pregnancy. Publications describe a small number of pregnancies worldwide and a high rate of miscarriage. We compiled the experience of women enrolled in the Australia and New Zealand Fontan (ANZ) Registry with regard to menarche, contraceptive use, pregnancy advice and pregnancy outcomes.
METHODS: Women within the ANZ Fontan Registry were contacted and asked to consent to receiving sequential questionnaires.
RESULTS: 156 women ≥ 18 years of age (including 4 deceased individuals) were identified, 101 women consented and 97 completed the initial questionnaire. Women were aged (median) 25 years (23-32); menarche occurred at a median 14 years (13-16). A wide variety of contraceptive methods was reported. 81% of women reported having received advice that pregnancy carried an increased risk or was inadvisable. Pregnancy was reported in a minority (n=27). Miscarriage (42.5%) and termination (7.5%) accounted for half the pregnancy outcomes and the babies were born early (median 31.5 weeks) and small (median 1350 g). Maternal complications of bleeding, arrhythmia and heart failure were reported with no early maternal mortality.
CONCLUSIONS: In women with a Fontan circulation the fertility onset is delayed and pregnancy has a higher rate of miscarriage. Successful pregnancy resulted in small and premature babies. Significant maternal morbidity occurred. Whether pregnancy with its volume loading has an adverse effect on the long-term outcome of women with a single ventricle remains to be elucidated. Crown
Copyright © 2016. Published by Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Congenital heart disease; Contraception; Fontan circulation; Menarche; Pregnancy; Women

Mesh:

Year:  2016        PMID: 26836494     DOI: 10.1016/j.ijcard.2016.01.180

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  7 in total

Review 1.  Current Therapy for Hypoplastic Left Heart Syndrome and Related Single Ventricle Lesions.

Authors:  Richard G Ohye; Dietmar Schranz; Yves D'Udekem
Journal:  Circulation       Date:  2016-10-25       Impact factor: 29.690

Review 2.  Congenital heart disease and pregnancy: A contemporary approach to counselling, pre-pregnancy investigations and the impact of pregnancy on heart function.

Authors:  Matthew Cauldwell; Michael Gatzoulis; Philip Steer
Journal:  Obstet Med       Date:  2017-02-05

Review 3.  Pregnancy in a woman with a Fontan circulation: A review.

Authors:  Emily Moroney; Elske Posma; Alicia Dennis; Yves d'Udekem; Rachael Cordina; Dominica Zentner
Journal:  Obstet Med       Date:  2017-11-22

4.  National In-Hospital Outcomes of Pregnancy in Women With Single Ventricle Congenital Heart Disease.

Authors:  R Thomas Collins; Di Chang; Adam Sandlin; Anthony Goudie; James M Robbins
Journal:  Am J Cardiol       Date:  2017-02-16       Impact factor: 3.133

5.  Four successful pregnancies in a patient with Fontan palliation and congenital heart disease: a case report.

Authors:  Khalid S Al Najashi; Syed Mehdi; Shazia Mohsin; Merna Atiyah; Hafez A Abdullah; Jassim Abdulhameed; Ahmed M Al Zahrani
Journal:  J Cardiothorac Surg       Date:  2017-11-28       Impact factor: 1.637

6.  Twin pregnancy complicated by total placenta previa in a Fontan-palliated patient: A case report.

Authors:  Aoi Morita; Saki Kido; Masahiro Hachisuga; Hazumu Nagata; Nobuhiro Hidaka; Kiyoko Kato
Journal:  Case Rep Womens Health       Date:  2018-10-26

7.  Timing of Pubertal Development in Boys and Girls With Congenital Heart Defects: A Nationwide Cohort Study.

Authors:  Louise F Udholm; Anne Gaml-Sørensen; Linn H Arendt; Nis Brix; Lea L H Lunddorf; Andreas Ernst; Ulla B Knudsen; Vibeke E Hjortdal; Cecilia H Ramlau-Hansen
Journal:  J Am Heart Assoc       Date:  2022-03-29       Impact factor: 6.106

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.